The exact cause of Other Specified Myelodysplastic and Myeloproliferative Neoplasms (MDS/MPN) is unknown. However, it is thought to be caused by a combination of genetic and environmental factors, such as exposure to certain chemicals, radiation, and infections.
Diagnosis of MDS/MPN is based on a physical examination and a review of medical history. A complete blood count (CBC) may also be used to evaluate the levels of red and white blood cells and platelets in the blood, as well as the presence of abnormal cells.
The differential diagnosis of MDS/MPN includes other conditions such as leukemia, lymphoma, aplastic anemia, and bone marrow failure syndromes.
Treatment of MDS/MPN depends on the type and severity of the disorder. Treatment options may include chemotherapy, radiation therapy, stem cell transplantation, and medications to treat specific symptoms.
The prognosis for MDS/MPN depends on the type and severity of the condition. In general, the prognosis is good for those with mild forms of the disorder, while those with more advanced forms may have a poorer prognosis.